Viseven

AUGUST 15, 2024

In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? This change is further driven by major regulatory bodies emphasizing Patient-Focused Drug Development (PFDD). Let’s break them down below.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

Pharmaceutical Technology

JUNE 25, 2025

Communication between European Union (EU) member states is ongoing to finalise the details of the legislation, but at its core, the EHDS will provide a single registry of patient data from across the continent. Trust is something that you earn, so how we communicate what’s coming out of this directive is very important.

Communication 52

Communication Hospitals Packaging Pharmaceutical Companies 52

Viseven

JUNE 18, 2025

Scientific communication : Drafting slide decks, scientific responses, medical information letters, and training content using generative models, ensuring scientific accuracy and compliance in messaging and content.

Labelling 52

Labelling Communication Drug Development Documentation 52

Pharma Marketing Network

OCTOBER 9, 2024

Understanding the Dynamics of Pharma Networks Pharma networks are intricate systems composed of various stakeholders, including pharmaceutical companies, healthcare professionals, regulatory bodies, and patients. Understanding the dynamics of these networks is essential for any entity looking to thrive in the pharmaceutical sector.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

pharmaphorum

JANUARY 31, 2022

The digital transformation is allowing pharmaceutical companies to expand their drug discovery capabilities and accelerate drug development. Access to and awareness of vaccines is more important than ever, especially in a globally connected world where outbreaks cannot easily be confined to a limited area.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 97

Pharmaceutical Technology

JUNE 19, 2025

Both modalities have emerged as the most used platform technologies in developing oligonucleotide-based drugs for CNS disorders since 2020. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51 billion) of these deals. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

DECEMBER 9, 2022

Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. Brazilian public spending on healthcare, drug pricing reforms and remote medicine. . <p>Early

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

JUNE 25, 2025

By GlobalData Learn more about Strategic Intelligence In light of the approvals of Leqembi and Kisunla, large pharmaceutical companies are increasingly investing in Alzheimer’s disease through high-value acquisitions. Stay proactive with real-time data and expert analysis.

Packaging 59

Packaging Biosimilars Communication Hospitals 59

PharmaKinnex

APRIL 28, 2022

Over the past few years, rare disease drugs have seen an increase in research and development from the big pharmaceutical companies. The above factors can yield higher sales, making rare disease drug development extremely lucrative and desirable. The power of inside sales begins here.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Viseven

NOVEMBER 9, 2022

Key Opinion Leaders play a critical role in the life sciences industry – pharmaceutical companies often engage them during clinical trials and drug commercialization. It’s a quantitative way to locate physicians leaders who influence the medical community.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

pharmaphorum

MAY 27, 2022

The standard operating procedures that guided practice for a generation were ripped up by the pandemic and the challenges for pharmaceutic company field force teams multiplied while the opportunities diminished. Good communication is a hallmark of business success.”. About the interviewees. He graduated from UNSW, with a B.A

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Pharmaceutical Technology

JULY 18, 2022

With the ever-rising costs of bringing a drug to market, pharmaceutical companies are increasingly looking at how they can improve the efficiency of their entire product development and drug commercialisation process. There is a risk for variation between batches.”.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Dosage Communication 52

Viseven

AUGUST 7, 2024

Medical writing refers to creating healthcare-related textual content that aims to improve doctor-patient communication and provide insights on industry topics. Medical writers must be outstanding communicators, capable of breaking down complex ideas for the public and healthcare professionals in a digestible way.

Communication 52

Communication Documentation Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

JANUARY 4, 2023

This article will cover the most important areas of AI influence on the pharma industry and new drugs development. What is Artificial Intelligence in Pharmaceutical Industry? Drug Development and Discovery. We analyzed the recent market research and are ready to share it with you.

Drug Development 52

Drug Development Medical Records Communication Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 28, 2023

For many years, the pharmaceutical industry has been accused of overlooking this patient population by instead targeting investments toward more prevalent indications. Orphan drug development is expanding Change is happening. With similar incentives offered by EU/EEA and UK law, orphan drug development has taken off.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Communication 52

Pharmaceutical Technology

OCTOBER 26, 2022

According to Tufts Center for the Study of Drug Development (CSDD), in a typical Phase Ill clinical trial, 119 protocol deviations are implemented on average, involving approximately one-third of all patients participating in that trial. 1 Tufts Center for the Study of Drug Development (CSDD); Jan/Feb 2022 Impact Report.

Drug Development 52

Drug Development Communication Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

DECEMBER 13, 2024

Improved communication channels also mean that patients can share health data and feedback directly with researchers, creating a more collaborative experience. Promote collaboration across departments Encourage open communication between teams like research, regulatory, and data management through shared digital platforms.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Documentation Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 26, 2022

To increase the likelihood of clinical success, drug developers must identify challenges and potential red flags early on in the candidate selection stage. This minimizes downstream risks, helps to determine a suitable synthetic route for scale-up, and facilitates an easier transition into the formulation development phase.

Compounding 52

Compounding Drug Development Communication Pharmaceutical Companies 52

pharmaphorum

APRIL 19, 2022

I think the most important thing is making a good team and also good communication within that team is very important. Drug development is never a swift process, and RudaCure still has many steps to take to bring its drugs to global markets. Everyone in our team is very valuable,” he said. “I Moving to the global stage.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Pharmaceutical Technology

APRIL 12, 2023

Evidence suggests that API manufacturing is gaining in complexity, as well as sophistication, and therefore adding to the risk profile of drug development. PAT, used correctly, should lead to better manufacturing processes and ultimately significant business benefits for the pharmaceutical company.

Controlled Substances 52

Controlled Substances Dosage Communication Pharmaceutical Companies 52

pharmaphorum

MARCH 30, 2021

“There’s a lot that drug development for more common diseases could learn from rare disease R&D”. I think there’s a lot that drug development for more common diseases could learn from rare disease R&D.”. We have to be innovative to get around those challenges. Rare diseases during COVID.

Hospitals 111

Hospitals Communication Drug Development Pharmaceutical Companies 111

Pharma Marketing Network

MAY 11, 2025

Build Brand Equity Through Value-Based Messaging Asian pharma marketing professionals must revisit how value is communicated. market still viable for Asian pharmaceutical companies? Companies need to offer differentiated value and prepare for increased competition and tighter pricing. Is the U.S.

Drug Pricing 59

Drug Pricing Biosimilars Communication Immunity 59

Viseven

DECEMBER 4, 2024

One of the most tragic was the thalidomide disaster, in which pregnant women prescribed the drug to treat morning sickness suffered severe birth defects. This made drug developers realize that flaws in the manufacturing process could go unnoticed. By the late 1970s, the concept of process validation was introduced.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

pharmaphorum

APRIL 11, 2022

Delivering value for patients doesn’t start and end in our R&D labs; actions can be implemented across all stages of the drug development lifecycle to encourage and embrace a pro-innovation environment. The role of innovation in value-based healthcare. About the author.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

Viseven

MAY 9, 2025

Source: [link] Demonstrating value Pharmaceutical companies are expected to go beyond simply proving that their treatments work they need to show that their products provide real, measurable benefits for both patients and healthcare systems. How Does the HEOR Model Work for Pharmaceutical Companies?

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. We talk a lot in clinical trials and drug development about benefit,” Dr Mullen said. But who is benefitting?

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 111

pharmaphorum

OCTOBER 28, 2020

Data defines modern therapeutics, but this is almost uniquely confined to the clinical trial stages of drug development. Identifying, recruiting, retaining and monitoring patients during this part of the cycle is estimated to cost pharma US$19 billion a year as companies seek to harvest patient experiences.

Vaccines 119

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 119

pharmaphorum

SEPTEMBER 9, 2021

Public health agencies and pharma pivoted in countless ways, from decentralising clinical trials and accelerating research and development, to enabling remote care and remote working with rapid digitisation. And we transformed so quickly because the key players communicated and collaborated. About the author.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. This was higher than the number of approvals in 2019 and 2020. Regulators are also paying close attention to the risks.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 12, 2023

The UK’s National Centre for the Replacement, Refinement and Reduction of Animals in Research or NC3Rs has worked with the pharmaceutical industry, researchers and regulators to develop guidance on several related issues in line with its objectives. However, the ABPI is more cautious. Please check your email to download the Report.

Vaccines 98

Vaccines Biosimilars Communication Pharmaceutical Companies 98

Viseven

SEPTEMBER 18, 2024

When COVID hit, the urgent need to accelerate drug development meant shrinking timelines from years to months, with no room for compromises on quality. Cloud-based tools allowed pharma companies to capture and share clinical data between research teams both securely and quickly.

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 20, 2023

We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ)

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52

Viseven

MAY 23, 2025

Companies have to adopt an omnichannel approach , merging their marketing tools, data, technologies, and people to ensure the best-in-class experience. Collaborations and partnerships In the pharmaceutical industry, collaborations play a huge role. In pharma, proper communication has the power to save lives.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 25, 2025

Vaccine R&D stagnation likely Although ACIP recommendations are separate from the US Food and Drug Administration (FDA)’s approvals, national immunisation recommendation provides a key pillar on which to guide pipeline development for a pharmaceutical company.

Vaccines 115

Vaccines Hospitals Packaging Communication 115

Pharmaceutical Technology

JUNE 27, 2025

It feels like in the US, pharmaceutical companies are capitalising on people’s frustration and desperation to lose weight.” Unintended compounded price point Compounded drugs are custom-made and unbranded medications that contain the same active ingredient as a marketed drug, such as semaglutide or tirzepatide via a prescription.

Drug Pricing 59

Drug Pricing Compounding Packaging Communication 59